Cancer Survival in Reunion Island , 1998-2008 (SUCRE)

Survie Des Personnes Atteintes de Cancer à la Réunion, 1998-2008 (SUCRE)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02900287

Acronym

SUCRE

Enrollment

18000

Registered

2016-09-14

Start date

2019-01-01

Completion date

2019-12-31

Last updated

2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Keywords

Survival, Cancer

Brief summary

Cancer survival is important to determine prognostic of patients and evaluate care and prevention health strategies. Sucre is the first study to describe cancer survival in Reunion Island. Sucre aims at evaluating five year cancer prognostic in Reunion Island by cancer site and gender. Sucre is a retrospective cohort study of cancer diagnosed between 01/01/1998 and 31/12/2008.

Detailed description

Data are extracted from Reunion Island Cancer Registry.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

15 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients domiciled in Reunion Island at diagnosis * Patients with at least 15 years of age at diagnosis * Patients with cancer diagnosis between 01/01/1998 and 31/12/2008

Exclusion criteria

* Cutaneous malignant cancer expected melanoma

Design outcomes

Primary

Measure	Time frame
5 years related survival rate by cancer site and gender	5 years

Secondary

Measure	Time frame
1, 3, 5 and 10 years related survival rate by cancer site and gender	1, 3, 5 and 10 years
1, 3, 5 and 10 years standardised survival rate by cancer site and gender	1, 3, 5 and 10 years
1, 3, 5 and 10 years related survival rate by age at diagnosis	1, 3, 5 and 10 years

Countries

Reunion

Outcome results